Skip to main content
Fig. 6 | Microbiome

Fig. 6

From: Metabolomic signatures distinguish the impact of formula carbohydrates on disease outcome in a preterm piglet model of NEC

Fig. 6

Selected plasma and cecal metabolites with differences by disease phenotype (a) or formula carbohydrate (b). Representative metabolites from the major pathways found to be differentially abundant in plasma and cecal content samples. Metabolite concentrations are shown on a mean-centered and standard deviation-scaled y-axis. Each metabolite shown was found to be significantly different (FDR-adjusted q < 0.01) either between healthy and NEC piglets or across formula groups by two-way ANOVA (formula group × disease phenotype)

Back to article page